Physician profile
Ashwin Mehta
NPI 1649324252
$3,924.60
in general payments reported to CMS, 2019-2025
19 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 76% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2021: $189 · 2022: $202 · 2023: $510 · 2024: $1,280 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,805 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,805.27 |
| Education | $279.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $727.00 | 2022-2025 | Tagrisso, Imfinzi |
| Tempus Ai, INC | $605.86 | 2024-2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $437.70 | 2021-2025 | |
| Pfizer INC. | $409.97 | 2024 | |
| Janssen Scientific Affairs, LLC | $221.81 | 2024 | Rybrevant |
| Coherus Oncology, INC. | $168.76 | 2023-2025 | Loqtorzi |
| Gilead Sciences, INC. | $147.59 | 2025 | Trodelvy |
| Abbvie INC. | $125.99 | 2025 | |
| G1 Therapeutics, INC. | $125.00 | 2023 | Cosela |
| Boston Scientific Corporation | $119.92 | 2019 | |
| Ethicon US, LLC | $117.88 | 2019 | |
| Janssen Biotech, INC. | $116.27 | 2025 | Rybrevant |
| Covidien Lp | $110.94 | 2019 | |
| Genzyme Corporation | $107.95 | 2023 | |
| Novocure INC. | $106.71 | 2024 | Optune Lua (Novottf-200t) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $99.43 | 2019 | |
| Medtronic, INC. | $77.51 | 2022 | |
| Lucid Diagnostics INC. | $63.79 | 2021 | |
| Intuitive Surgical, INC. | $34.52 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwin Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.